Surviving and Thriving with ADHD: Part 2
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood, affecting as many as 5-10% of children and adolescents and 2.5- 5% of adults. It is a serious public health concern because of its high prevalence, long-term course, and functional impairment at home, school and work. ADHD can be effectively managed with a variety of treatment options, including parent training, school interventions, medications, and behavioral strategies... Read More »
The Hypothyroid Patient
About 12% of the US population has some form of thyroid disease, and more than half of them are unaware of their condition. Hypothyroidism is the most common thyroid condition. It affects about 2% of women and 0.1-0.2% of men; however, in adults over 60 years old, 6% of women and 2.5% of men have the condition.
Hypothyroidism is a chronic disease that requires lifelong treatment; fortunately, it can be easily managed with thyroid hormone replacement medication. The recommended treatment is levothyroxine, which was the most frequently prescribed drug in the US in 2019. Other thyroid hormone replacement medications are available in various products and strengths... Read More »
Surviving and Thriving with ADHD: Part 1. Stimulant and Nonstimulant Treatment
There has been an increase in prescription medications, mainly stimulants, for the treatment of attention deficit hyperactivity disorder (ADHD) along with an explosion of new formulations. A 2016 CDC report estimates that about 9% of children 2 to 17 years of age (6.1 million) have been diagnosed with ADHD. Among the children with ADHD, 6 out of 10 were taking ADHD medication. The lifetime prevalence of ADHD has been estimated to be as high as 8.1%.... Read More »
